<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>The Neuroscience Journal of Shefaye Khatam</title>
<title_fa>مجله علوم اعصاب شفای خاتم</title_fa>
<short_title>Shefaye Khatam</short_title>
<subject>Medical Sciences</subject>
<web_url>http://shefayekhatam.ir</web_url>
<journal_hbi_system_id>1</journal_hbi_system_id>
<journal_hbi_system_user>admin</journal_hbi_system_user>
<journal_id_issn>2322-1887</journal_id_issn>
<journal_id_issn_online>2345-4814</journal_id_issn_online>
<journal_id_pii></journal_id_pii>
<journal_id_doi>10.61882/shefa</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid></journal_id_sid>
<journal_id_nlai></journal_id_nlai>
<journal_id_science></journal_id_science>
<language>fa</language>
<pubdate>
	<type>jalali</type>
	<year>1396</year>
	<month>1</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2017</year>
	<month>4</month>
	<day>1</day>
</pubdate>
<volume>5</volume>
<number>2</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa>P 16: The Effect of Reducing CCL11 on Multiple Sclerosis Treatment by Using Heterochronic Parabiosis Techniques</title_fa>
	<title>P 16: The Effect of Reducing CCL11 on Multiple Sclerosis Treatment by Using Heterochronic Parabiosis Techniques</title>
	<subject_fa>تحقیقات پایه در علوم اعصاب</subject_fa>
	<subject>Basic research in Neuroscience</subject>
	<content_type_fa>پژوهشي</content_type_fa>
	<content_type>Research --- Open Access, CC-BY-NC</content_type>
	<abstract_fa>&lt;table border=&quot;0&quot; cellpadding=&quot;5px&quot; cellspacing=&quot;2&quot; dir=&quot;rtl&quot; id=&quot;table_article&quot; style=&quot;font-family: Tahoma; background-color: rgb(251, 250, 249); break-inside: avoid !important;&quot; width=&quot;100%&quot;&gt;
	&lt;tbody style=&quot;break-inside: avoid !important; font-size: 12px; margin-top: 0px; line-height: 2.2; margin-bottom: 0px; text-align: justify;&quot;&gt;
		&lt;tr style=&quot;break-inside: avoid !important;&quot;&gt;
			&lt;td class=&quot;abstractmed&quot; colspan=&quot;2&quot; style=&quot;break-inside: avoid !important;&quot;&gt;
			&lt;p style=&quot;font-size: 12px; margin-top: 0px; margin-bottom: 0px; text-align: center;&quot;&gt;&lt;span style=&quot;color: rgb(0, 0, 0); font-size: 12px; line-height: 20.8px;&quot;&gt;لطفاً به چکیده انگلیسی مراجعه شود.&lt;/span&gt;&lt;/p&gt;
			&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr style=&quot;break-inside: avoid !important;&quot;&gt;
		&lt;/tr&gt;
	&lt;/tbody&gt;
&lt;/table&gt;

&lt;p&gt;&lt;/p&gt;
</abstract_fa>
	<abstract>&lt;p&gt;&lt;strong&gt;Introduction:&lt;/strong&gt; Multiple sclerosis is a chronic neuroinflammatory disease that leads to distribute neurodegeneration in the grey and white matter of the brain. &amp;nbsp;In MS, age-related iron accumulation, chronic oxidative injury and activation of microglia are key factors to create neurodegeneration. Also concentration of CCL&lt;sub&gt;11&lt;/sub&gt; is increased in &amp;nbsp;&amp;nbsp;multiple sclerosis. CCL&lt;sub&gt;11&lt;/sub&gt; can amplify glutamate mediated neurotoxicity and inhibit neurogenesis. &lt;strong&gt;Materials and Methods:&lt;/strong&gt; A model of Heterochronic Parabiosis is created with joining a sick animal to healthy young animal. &lt;strong&gt;Results:&lt;/strong&gt; It is expected by reducing CCl&lt;sub&gt;11&lt;/sub&gt;, healthy young blood could be effective in slowing and improving disease. &lt;strong&gt;Conclusion:&lt;/strong&gt; Other studies suggest that multiple sclerosis treatment should be based on a combination of anti-inflammatory, regenerative, and neuroprotective strategies. By using heterochronic parabiosis has been shown that, young blood can rejuvenate and improve the regenerative capacity of peripheral tissues and central nervous system in aged animals. GDF&lt;sub&gt;11&lt;/sub&gt; is a systemic &amp;lsquo;pro-youthful&amp;#39; factor in young parabiont, that promote neurogenesis and rejuvenate regeneration capacity of CNS and promote tissue regeneration.&amp;nbsp; So it seems high concentration of GDF&lt;sub&gt;11&lt;/sub&gt; and low concentration of ccl&lt;sub&gt;11&lt;/sub&gt; in healthy young parabiont may be effective on regenerative capacity of central nervous system in MS animals.&lt;/p&gt;
</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Multiple sclerosis, Neurodegeneration, Heterochronic parabiosis, CCL11, GDF11</keyword>
	<start_page>47</start_page>
	<end_page>47</end_page>
	<web_url>http://shefayekhatam.ir/browse.php?a_code=A-10-24-865&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Leila </first_name>
	<middle_name></middle_name>
	<last_name>Kamali-Dolatabadi</last_name>
	<suffix></suffix>
	<first_name_fa>Leila </first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa>Kamali-Dolatabadi</last_name_fa>
	<suffix_fa></suffix_fa>
	<email>leili_kamali@yahoo.com</email>
	<code>100319475328460011842</code>
	<orcid>100319475328460011842</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Department of Neuroscience, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz, Iran</affiliation>
	<affiliation_fa>Department of Neuroscience, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz, Iran</affiliation_fa>
	 </author>


	<author>
	<first_name>Masoomeh</first_name>
	<middle_name></middle_name>
	<last_name>Mohamadpour</last_name>
	<suffix></suffix>
	<first_name_fa>Masoomeh</first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa>Mohamadpour</last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>100319475328460011843</code>
	<orcid>100319475328460011843</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Histomorphometry and Stereology Research Center. Shiraz University of Medical Science. Shiraz. Iran</affiliation>
	<affiliation_fa>Histomorphometry and Stereology Research Center. Shiraz University of Medical Science. Shiraz. Iran</affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
